Last reviewed · How we verify
NCT03979729
Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography
trial testing Routine Screening Mammogram (3D + 2D) in Breast Cancer Screening in 75 participants. Completed in 3 June 2021.
7 May 2020
Quick facts
| Lead sponsor | New Mexico Cancer Research Alliance |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 22 September 2016 |
| Primary completion | 7 May 2020 |
| Estimated completion | 3 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Routine Screening Mammogram (3D + 2D)
- Routine Screening Mammogram (2D)
- No Screening Mammogram
Conditions studied
- Breast Cancer Screening — all drugs for Breast Cancer Screening →
Sponsor
New Mexico Cancer Research Alliance — full company profile →
Who can join
40 and older, female only, with Breast Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Three-dimensional (3D) + two-dimensional (2D)- mammography may have particular value for minority, rural, and underserved women in New Mexico by decreasing recall rates and improving diagnostic sensitivity, thus alleviating some of the unique burdens associated with breast cancer screening in the multi-ethnic and underserved New Mexico patient population. Primary objective: To compare recall rates using 3D + 2D- vs. 2D- mammogram in New Mexico women undergoing screening mammogram between 2013 and 2016. Secondary objectives: Evaluate knowledge, attitudes, perceived barriers, intentions, decisional influences, and other psychosocial/cultural factors influencing breast cancer screening among medically underserved patients and assess what impact 3D + 2D-mammography might have on those perceptions; Determine primary care providers' knowledge, attitudes, beliefs, and preferences regarding 3D + 2D- vs. 2D- mammography; evaluate breast cancer detection rate and biopsy positive predictive value for screening mammograms using 3D + 2D- vs. 2D using PENRAD data; evaluate screening outcome, compliance with recall recommendations, breast cancer detection rate, positive predictive value, and demographics of interest in New Mexico women undergoing screening and offered 3-D mammography (retrospective chart review).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Breast Cancer Screening Among Medically Underserved Women in New Mexico: Potential for Lower Recall Rates with Digital Breast Tomosynthesis.
Manda-Mapalo MT, Fine SG, Safadi S, Lee JH, et al · · 2020 · PMID 32991242 · DOI 10.1089/jwh.2020.8402
Verify or expand the search:
- PubMed search for NCT03979729
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Screening
Currently open trials in the same condition.
- NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
- NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
- NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
- NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
- NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting
Other New Mexico Cancer Research Alliance trials
Trials by the same sponsor.
- NCT07436793 — Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial · Phase 2 · not yet recruiting
- NCT06260332 — Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors · NA · active not recruiting
- NCT06207864 — Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing · NA · recruiting
- NCT05176743 — Food Insecurity in Oncology · NA · completed
- NCT04259762 — Enhancing Cancer Prevention and Control Pathways-Native Health Initiative · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03979729 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New Mexico Cancer Research Alliance
- Last refreshed: 5 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03979729.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing